Inotropes, such as milrinone, do not improve outcomes in patients admitted with acute decompensated heart failure or increase urine output. Inotropes may be considered in patients with low-output heart failure (low pulse pressure, cool extremities, presence of S3) to improve cardiac output but should not be used in the routine therapy of patients admitted with heart failure.
top of page
Internal Medicine
Public·54 members
bottom of page